2009
DOI: 10.1016/j.bmc.2009.06.023
|View full text |Cite
|
Sign up to set email alerts
|

Interaction of drug based binuclear mixed-ligand complexes with DNA

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 25 publications
(10 citation statements)
references
References 39 publications
0
10
0
Order By: Relevance
“…Obtaining the most accurate chemical structure of silver complexes is closely related to its biological properties, such as the identification of pharmacophores, 82 interaction with DNA and antibacterial activity, 83 , 84 blocking of topoisomerase II enzymes (inhibiting the DNA repair activity) and possible anti-cancer, anti-fungal and anti-parasitic effects. 2 , 4 , 18 …”
Section: Discussionmentioning
confidence: 99%
“…Obtaining the most accurate chemical structure of silver complexes is closely related to its biological properties, such as the identification of pharmacophores, 82 interaction with DNA and antibacterial activity, 83 , 84 blocking of topoisomerase II enzymes (inhibiting the DNA repair activity) and possible anti-cancer, anti-fungal and anti-parasitic effects. 2 , 4 , 18 …”
Section: Discussionmentioning
confidence: 99%
“…From this perspective, the synthesis of new metal complexes and evaluation of their antibacterial activity have been considered by the global community as part of the solution (Saha et al, 2009;Rafique et al, 2010). Based on this, a good number of mononuclear (Ghatole et al, 2012;Pasdar et al, 2015;Atakilt Abebe and Tizazu Hailemariam, 2016;Atakilt Abebe and Getinet Tamiru, 2018), binuclear (Patel et al, 2009;Krishna et al, 2013;Gurumoorthy et al, 2014;Panda et al, 2015;) and metal mixed-ligand complexes have been reported in the literature. In particular, Co (II) containing mixed ligand complexes appeared promising in solving the aforementioned problems (Patel et al, 2009;Chang et al, 2010).…”
Section: Introductionmentioning
confidence: 92%
“…Based on this, a good number of mononuclear (Ghatole et al, 2012;Pasdar et al, 2015;Atakilt Abebe and Tizazu Hailemariam, 2016;Atakilt Abebe and Getinet Tamiru, 2018), binuclear (Patel et al, 2009;Krishna et al, 2013;Gurumoorthy et al, 2014;Panda et al, 2015;) and metal mixed-ligand complexes have been reported in the literature. In particular, Co (II) containing mixed ligand complexes appeared promising in solving the aforementioned problems (Patel et al, 2009;Chang et al, 2010). In most of these reports, however, Co (II) complexes did not work against Gramnegative bacteria (Shalash and Ali, 2017).…”
Section: Introductionmentioning
confidence: 92%
“…All the ligands N,N 0 -bis-(4-methoxy-phenyl)-1,2-dimethylethane-1,2-diimine (L 2 ), N,N 0 -bis-(4-methoxy-benzylidene)-ethane-1,2-diamine (L 3 ), N,N 0 -dicyclohexylidene-benzene-1,2-diamine (L 4 ), N,N 0 -bis-(4-methoxy-benzylidene)-benzene-1,2-diamine (L 5 ), N,N 0 -bis-(3-chlorophenyl)-1,2-diphenylethane-1,2-diimine (L 6 ), bis(benzylidene)ethylenediamine (L 7 ), N,N 0 -bis-(4-methoxyphenyl)-1,2-diphenylethane-1, 2-diimine (L 8 ), N,N 0 -bis-(phenyl)-1,2-dimethyl-ethane-1, 2-diimine (L 9 ), 4-methoxy-N-(thiophene-2-ylmethylene) aniline (L 10 ), 3-amino-2-phenyl-3H-quinazolin-4-one (L 11 ), N,N 0 -bis-(1-phenyl-ethylidene)-ethane-1,2-diamine (L 12 ), N,N 0 -dicyclohexylidene-napthalene-1,8-diamine (L 13 ), N,N 0 -(1, 2-diphenyl-ethane-1,2-diylidene)dianiline (L 14 ), N,N 0 -bis-(1-phenyl-ethylidene)-benzene-1,2-diamine (L 15 ) were prepared according to the literature Patel, 2007, 2008a, b;Patel et al, 2009b) except di-pyridin-2-ylamine (L 1 ), ethylenediamine (L 16 ), o-phenylenediamine (L 17 ) and 1,8-aminonaphathalene (L 18 ) which were used as such. The structures and the physicochemical parameters are represented in Fig.…”
Section: Synthesis Of Ligandsmentioning
confidence: 99%